Similar articles for PMID: 29937237

Year	Number of Results
1994	1
1996	1
2000	3
2001	3
2002	2
2003	2
2005	1
2007	4
2008	5
2009	4
2010	3
2011	8
2012	4
2013	7
2014	10
2015	13
2016	9
2017	8
2018	11
2019	10
2020	5
2021	5
2022	1
2023	1
2024	0

1

Are Corticosteroids Beneficial in the Treatment of Community-Acquired Pneumonia?

Seagraves T, Gottlieb M. Seagraves T, et al. Ann Emerg Med. 2019 Jul;74(1):e1-e3. doi: 10.1016/j.annemergmed.2018.05.001. Epub 2018 Jun 22. Ann Emerg Med. 2019. PMID: 29937237 No abstract available.

2

Corticosteroids in treating community-acquired pneumonia: has the time really come?

Blot M, Salmon-Rousseau A, Chavanet P, Piroth L. Blot M, et al. Clin Microbiol Infect. 2017 May;23(5):276-278. doi: 10.1016/j.cmi.2016.09.002. Epub 2016 Sep 16. Clin Microbiol Infect. 2017. PMID: 27647562 Free article. No abstract available.

3

Corticosteroids for Severe Community-Acquired Pneumonia: Time to Change Clinical Practice.

Restrepo MI, Anzueto A, Torres A. Restrepo MI, et al. Ann Intern Med. 2015 Oct 6;163(7):560-1. doi: 10.7326/M15-1805. Ann Intern Med. 2015. PMID: 26258646 No abstract available.

4

Efficacy and safety of adjunctive corticosteroids therapy for patients with severe community-acquired pneumonia: A systematic review and meta-analysis.

Huang J, Guo J, Li H, Huang W, Zhang T. Huang J, et al. Medicine (Baltimore). 2019 Mar;98(13):e14636. doi: 10.1097/MD.0000000000014636. Medicine (Baltimore). 2019. PMID: 30921179 Free PMC article.

5

Low-dose corticosteroids during severe community-acquired pneumonia: end of the story.

Ricard JD, Messika J. Ricard JD, et al. Eur Respir J. 2015 Feb;45(2):305-7. doi: 10.1183/09031936.00225414. Eur Respir J. 2015. PMID: 25653260 Free article. No abstract available.

6

Advances in severe community-acquired pneumonia.

Wang J, Song YL. Wang J, et al. Chin Med J (Engl). 2019 Aug 20;132(16):1891-1893. doi: 10.1097/CM9.0000000000000366. Chin Med J (Engl). 2019. PMID: 31335475 Free PMC article. No abstract available.

7

Corticosteroids in Patients Hospitalized With Community-Acquired Pneumonia: Systematic Review and Individual Patient Data Metaanalysis.

Briel M, Spoorenberg SMC, Snijders D, Torres A, Fernandez-Serrano S, Meduri GU, Gabarrús A, Blum CA, Confalonieri M, Kasenda B, Siemieniuk RAC, Boersma W, Bos WJW, Christ-Crain M; Ovidius Study Group; Capisce Study Group; STEP Study Group. Briel M, et al. Clin Infect Dis. 2018 Jan 18;66(3):346-354. doi: 10.1093/cid/cix801. Clin Infect Dis. 2018. PMID: 29020323

8

Corticosteroid treatment in severe community-acquired pneumonia: duration of treatment affects control of systemic inflammation and clinical improvement.

Nawab QU, Golden E, Confalonieri M, Umberger R, Meduri GU. Nawab QU, et al. Intensive Care Med. 2011 Sep;37(9):1553-4. doi: 10.1007/s00134-011-2274-5. Epub 2011 Jun 18. Intensive Care Med. 2011. PMID: 21688102 No abstract available.

9

Nonsteroidal anti-inflammatory drugs in community-acquired pneumonia.

Ricard JD, Messika J. Ricard JD, et al. Eur Respir J. 2015 Sep;46(3):876-7. doi: 10.1183/09031936.00048715. Eur Respir J. 2015. PMID: 26324696 Free article. No abstract available.

10

Nonsteroidal anti-inflammatory drugs in community-acquired pneumonia.

Crawford E, Allen M, Mustfa N, Stone H. Crawford E, et al. Eur Respir J. 2015 Sep;46(3):875-6. doi: 10.1183/09031936.00031615. Eur Respir J. 2015. PMID: 26324695 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

109 results

Results by year